1 |
Diabetic kidney disease in pediatric patients: A current review |
|
| | Carmen Muntean, Iuliana Magdalena Starcea, Claudia Banescu | | | World Journal of Diabetes. 2022; 13(8): 587 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes |
|
| | Nanees Abdel-Badie Salem,Rania Mostafa El Helaly,Ibrahim Maroof Ali,Hala Abd Alem Ebrahim,Mostafa Mahmoud Alayooti,Huda Ahmed El Domiaty,Hadil Mohamed Aboelenin | | | Pediatric Diabetes. 2020; | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model |
|
| | Abdallah Mahmoud El-Ebidi,Tahia H Saleem,Mohamed Gamal El-din Saadi,Hala Abdallah Mahmoud,Zeinab Mohamed,Hoda S Sherkawy | | | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 3807 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Role of urinary podocalyxin in early diagnosis of diabetic nephropathy |
|
| | Irena Kostovska,Katerina Tosheska Trajkovska,Svetlana Cekovska,Sonja Topuzovska,Julijana Brezovska Kavrakova,Goce Spasovski,Ognen Kostovski,Danica Labudovic | | | Romanian Journal of Internal Medicine. 2020; 58(4): 233 | | | [Pubmed] [Google Scholar] [DOI] | |
|